LUNG (Pulmonx Corp.) רווחיות מכירות לפי רווח גולמי

Pulmonx Corporation (LUNG) relies on streamlined medical logistics for the delivery of lung systems to clinics. However, slow technology adoption and insurance limits create risks for profitability. Dominance in the emphysema valve segment ensures high profitability. The gross margin level on the GURU.Markets chart currently stands at 77.10, reflecting the current level of the metric.
פילוחי מדדים מקיפים ואנליטיקה עבור Pulmonx Corp. (LUNG)

Pulmonx Corporation (LUNG) is optimizing the production of lung equipment by implementing ESG recycling standards and resource-saving packaging design to reduce costs. This process directly impacts the gross margin percentage, which measures the portion of revenue remaining after deducting the cost of goods sold, allowing investors to assess cost management efficiency and the company's ability to generate liquidity to service its obligations.